
Key Milestones in Microbiome Science and Viome History
Global Advances
2010 – 2016: Global Foundations in Microbiome Science
2012: NIH completes the Human Microbiome Project, establishing the critical role of trillions of microbes in human health.
2013: Significant studies link the gut microbiome to obesity and metabolic disorders.
2015: Discovery and validation of the gut-brain axis confirm microbial impact on mood, memory, and behavior.
2010-2016: Dr Vuyisich led the development of the metatranscriptomic technology at Los Alamos National Lab. This tech quantifies at least 100 times more health-related biomarkers than any other lab technology.
Viome Begins
2016
- Naveen Jain founded Bluespin in 2015 for early disease detection. Changed its name to Viome in 2016.
- Viome obtained an exclusive and perpetual license for metatranscriptomic RNA sequencing technology from Los Alamos National Laboratory.
- Momchilo Vuyisich and Guru Banavar join Viome
- Viome built an automated CLIA lab in New Mexico
2017
- Launched the Gut Intelligence at-home test to decode microbial activity with an at-home test.
Breakthroughs & Expansion
2019
- Surpassed 100,000 samples analyzed.
- Completed a landmark Glycemic Response study linking microbial activity to individual blood sugar responses.
2020
- Launched New Health Intelligence Test, analyzing human and microbial gene expression from blood.
2021
- CancerDetect™ achieves FDA Breakthrough Device Designation for accelerated review for early oral cancer detection.
- Viome Health Sciences launched to innovate diagnostics and therapeutics targeting chronic diseases and longevity.
Personalized Health at Scale
2022
- Surpassed 400,000 samples analyzed.
- Launched Full Body Intelligence™ Test, integrating RNA from stool, blood, and saliva.
- Scientific community emphasizes microbial dysbiosis role in influencing various aspects of health, including metabolic, cardiovascular, and cognitive function.
2023
- Surpassed 600,000 samples analyzed.
- Launched VRx MyBiotics Oral Lozenges and Oral Health Pro for clinical dental markets.
The Future is Now
2024
- Surpassed 1,000,000 samples, creating the world's largest microbial gene expression dataset.
- Global acknowledgment of microbial imbalance in overall health and how shifts in balance influence immune function, cognitive health, and other biological processes.
2025
- Viome’s AI database surpasses 100 quadrillion molecular data points, enriched with global peer-reviewed microbiome studies.

